AUM BIOSCIENCES
AUM Biosciences is an oncology-focused biotechnology company that aims to accelerate the development of innovative, affordable medicines for patients in Asia and around the world. AUM Biosciences focuses on early-stage development of innovative medicines for the treatment of Asian-prevalent cancers.
AUM BIOSCIENCES
Industry:
Biotechnology Oncology
Founded:
2018-01-01
Address:
Singapore, Central Region, Singapore
Country:
Singapore
Website Url:
http://www.aumbiosciences.com
Total Employee:
11+
Status:
Active
Contact:
+65 6808 6034
Total Funding:
28.48 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Apple Mobile Web Clips Icon Google Font API WordPress Font Awesome IPv6 Contact Form 7 WPForms Akamai Hosted
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Avant Meats
Avant Meats is a technology company with patent-pending solutions to produce animal meat and protein without the animal
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Current Employees Featured
Founder
Investors List
Everlife
Everlife investment in Series A - AUM Biosciences
SPRIM
SPRIM investment in Series A - AUM Biosciences
The Agency for Science, Technology and Research
The Agency for Science, Technology and Research investment in Series A - AUM Biosciences
Official Site Inspections
http://www.aumbiosciences.com Semrush global rank: 11.97 M Semrush visits lastest month: 138
- Host name: 192.194.178.68.host.secureserver.net
- IP address: 68.178.194.192
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "AUM Biosciences"
About – Aum - AUM Biosciences
Industry veterans with successful track records in developing & commercializing innovative cancer therapiesSee details»
Overview – Aum - AUM Biosciences
AUM Biosciences is a global clinical-stage biotech company, focused on discovering, developing and advancing a pipeline of precision oncology therapeutics designed to deploy multi-faceted inhibition strategies to reverse …See details»
AUM Biosciences - Crunchbase Company Profile
LinkedIn — AUM Biosciences on LinkedIn: #aumbiosciences #innovation #sciencediplomacy #nscebmeeting #technology… News • Jun 15, 2023 Seeking Alpha — AUM Biosciences terminates merger with SPAC Mountain Crest VSee details»
AUM Biosciences - LinkedIn
AUM Biosciences | 2,743 followers on LinkedIn. Advancing precision oncology therapeutics designed to deploy multi-faceted inhibition to reverse cancer resistance | AUM Biosciences is focused on ...See details»
AUM Biosciences - Devex
Learn more about AUM Biosciences's jobs, projects, latest news, contact information and geographical presence. AUM Biosciences is at the forefront of disrupting the drug …See details»
AUM Biosciences - PharmaBoardroom
Jun 11, 2019 Vishal Doshi – Chairman and CEO, AUM Biosciences, Singapore. Vishal Doshi, founder and CEO of AUM Biosciences, shares his motivation behind establishing the company and his mission to build an ecosystem within …See details»
Aum Biosciences (Singapore) Funding: $28.5M
Nov 26, 2024 AUM Biosciences is committed to addressing the unmet medical needs by developing innovative and affordable oncology therapeutics for...See details»
AUM Biosciences - Craft
AUM Biosciences is an oncology-focused biotechnology company. It develops highly selective targeted oncology therapeutics for the treatment of hepatocellular carcinoma, head and neck …See details»
AUM Biosciences Company Overview, Contact Details
Oct 12, 2021 Aumbiosciences partnered with Handok Inc. on May 20th '21. For instance in May, 2021 AUM Biosciences have entered into strategic collaboration with Handok Inc. and CMG …See details»
Our Story – Aum - AUM Biosciences
AUM is focused on developing a robust industry leading pipeline of best-in-class and first-in-class small molecule therapies, leveraging the latest in precision and digital medicine tools.See details»
AUM Biosciences and Asymchem Complete Phase II API
Oct 20, 2022 To know more, visit www.aumbiosciences.com. DISCLAIMER. ... Organization Profile. Asymchem. Related Organization(s) AUM Biosciences. Contact Cision. 866-245-2317 …See details»
AUM Biosciences (@AumBiosciences) / Twitter
Jun 25, 2018 #Oncology focused #Biotechnology company at the forefront of disrupting the drug development process, to enable affordable and timely #cancer care.See details»
AUM Biosciences Enters into Collaboration with Roche for Clinical ...
May 10, 2022 SINGAPORE and BETHESDA, MD, May 10, 2022 (GLOBE NEWSWIRE) -- AUM Biosciences, a global clinical-stage biotech company focused on discovering and developing …See details»
Career – Aum - AUM Biosciences
AUM Biosciences is built and led by a team of visionaries and industry veterans with decades of research and healthcare experience. Our work culture stems from integrity, transparency and …See details»
AUM Biosciences and Newsoara Biopharma Announce a 5-year ...
Nov 18, 2020 AUM grants Newsoara exclusive license in oncology for current and future pipeline for up to 6 oncology molecules in the Greater China Region; AUM will receive up to $135M in …See details»
AUM Biosciences, a Global Biotechnology Company Developing
Oct 20, 2022 The transaction reflects a pre-money equity value of $400 million for AUM Biosciences; Transaction is expected to provide $69 million of gross proceeds (assuming no …See details»
Pipeline Overview – Aum
Tel: +65 6808 6034. Fax: +65 6808 6699. Email: [email protected]@aumbiosciences.comSee details»
AUM Biosciences Enters into Collaboration with Roche for
May 10, 2022 SINGAPORE and BETHESDA, MD, May 10, 2022 (GLOBE NEWSWIRE) -- AUM Biosciences, a global clinical-stage biotech company focused on discovering and developing …See details»
Clinical Trials – Aum - AUM Biosciences
Clinical trials are a benchmark to test the efficiency and safety of drug therapies throughout the drug design process. As thousands of patients volunteer across all three phases of drug …See details»